Literature DB >> 30989372

Is Parkinson's disease a chronic low-grade inflammatory bowel disease?

Malvyne Rolli-Derkinderen1,2,3, Laurène Leclair-Visonneau1,2,4, Arnaud Bourreille1,2,3, Emmanuel Coron1,2,3, Michel Neunlist1,2,3, Pascal Derkinderen5,6,7.   

Abstract

While the pathogenesis of Parkinson's disease is not fully understood, there is increasing evidence that inflammatory responses in the brain are implicated in both disease initiation and progression. The inflammatory process in Parkinson's disease is, however, not limited to the brain but also involves the gastrointestinal tract. High amounts of cytokines and inflammatory markers are found in the colon of Parkinson's disease patients and there is now strong epidemiological and genetical evidence linking Parkinson's disease to inflammatory bowel diseases. Recent findings obtained in both experimental inflammatory bowel diseases and Parkinson's disease further support a bidirectional link between gastrointestinal inflammation and brain neurodegeneration. Altogether, these observations suggest a role for gastrointestinal inflammation in the initiation and progression of Parkinson's disease.

Entities:  

Keywords:  Crohn’s disease; Enteric nervous system; Inflammatory bowel disease; LRRK2; Parkinson’s disease; Ulcerative colitis

Mesh:

Substances:

Year:  2019        PMID: 30989372     DOI: 10.1007/s00415-019-09321-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  42 in total

1.  Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders.

Authors:  Ellen Gelpi; Judith Navarro-Otano; Eduardo Tolosa; Carles Gaig; Yaroslau Compta; María Jesús Rey; Maria José Martí; Isabel Hernández; Francesc Valldeoriola; Ramon Reñé; Teresa Ribalta
Journal:  Mov Disord       Date:  2014-01-02       Impact factor: 10.338

2.  Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study.

Authors:  Jung-Chun Lin; Chin-Sheng Lin; Chin-Wang Hsu; Cheng-Li Lin; Chia-Hung Kao
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

3.  Meta-analysis of published studies identified eight additional common susceptibility loci for Crohn's disease and ulcerative colitis.

Authors:  Junji Umeno; Kouichi Asano; Tomonaga Matsushita; Takayuki Matsumoto; Yutaka Kiyohara; Mitsuo Iida; Yusuke Nakamura; Naoyuki Kamatani; Michiaki Kubo
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

4.  Occurrence of Crohn's disease with Parkinson's disease.

Authors:  Shinsuke Fujioka; Sadie E Curry; Kathleen D Kennelly; Pawel Tacik; Michael G Heckman; Yoshio Tsuboi; Audrey J Strongosky; Jay A van Gerpen; Ryan J Uitti; Owen A Ross; Tsuneya Ikezu; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2017-02-10       Impact factor: 4.891

5.  CARD15 variants in patients with sporadic Parkinson's disease.

Authors:  Monika Bialecka; Mateusz Kurzawski; Gabriela Klodowska-Duda; Grzegorz Opala; Stefania Juzwiak; Grzegorz Kurzawski; Eng-King Tan; Marek Drozdzik
Journal:  Neurosci Res       Date:  2006-12-14       Impact factor: 3.304

Review 6.  Can the gut be the missing piece in uncovering PD pathogenesis?

Authors:  Guillaume Chapelet; Laurène Leclair-Visonneau; Thomas Clairembault; Michel Neunlist; Pascal Derkinderen
Journal:  Parkinsonism Relat Disord       Date:  2018-11-12       Impact factor: 4.891

7.  Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Linda Vedders; Lihfen Lue; Charles L White Iii; Haru Akiyama; John N Caviness; Holly A Shill; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2010-03-21       Impact factor: 17.088

8.  Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.

Authors:  Shin Maeda; Li-Chung Hsu; Hongjun Liu; Laurie A Bankston; Mitsutoshi Iimura; Martin F Kagnoff; Lars Eckmann; Michael Karin
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

9.  Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.

Authors:  Inga Peter; Marla Dubinsky; Susan Bressman; Andrew Park; Changyue Lu; Naijun Chen; Anthony Wang
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

10.  Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease.

Authors:  Ken Y Hui; Heriberto Fernandez-Hernandez; Jianzhong Hu; Adam Schaffner; Nathan Pankratz; Nai-Yun Hsu; Ling-Shiang Chuang; Shai Carmi; Nicole Villaverde; Xianting Li; Manual Rivas; Adam P Levine; Xiuliang Bao; Philippe R Labrias; Talin Haritunians; Darren Ruane; Kyle Gettler; Ernie Chen; Dalin Li; Elena R Schiff; Nikolas Pontikos; Nir Barzilai; Steven R Brant; Susan Bressman; Adam S Cheifetz; Lorraine N Clark; Mark J Daly; Robert J Desnick; Richard H Duerr; Seymour Katz; Todd Lencz; Richard H Myers; Harry Ostrer; Laurie Ozelius; Haydeh Payami; Yakov Peter; John D Rioux; Anthony W Segal; William K Scott; Mark S Silverberg; Jeffery M Vance; Iban Ubarretxena-Belandia; Tatiana Foroud; Gil Atzmon; Itsik Pe'er; Yiannis Ioannou; Dermot P B McGovern; Zhenyu Yue; Eric E Schadt; Judy H Cho; Inga Peter
Journal:  Sci Transl Med       Date:  2018-01-10       Impact factor: 17.956

View more
  24 in total

Review 1.  Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.

Authors:  David K Simon; Caroline M Tanner; Patrik Brundin
Journal:  Clin Geriatr Med       Date:  2019-08-24       Impact factor: 3.076

Review 2.  An Alternative Explanation for Alzheimer's Disease and Parkinson's Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins.

Authors:  Kevin Roe
Journal:  Neurochem Res       Date:  2021-10-20       Impact factor: 3.996

Review 3.  The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic.

Authors:  Ai Huey Tan; Shen Yang Lim; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2022-06-24       Impact factor: 44.711

Review 4.  The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease.

Authors:  Runing Yang; Ge Gao; Hui Yang
Journal:  Front Aging Neurosci       Date:  2022-06-24       Impact factor: 5.702

Review 5.  Gastrointestinal mucosal biopsies in Parkinson's disease: beyond alpha-synuclein detection.

Authors:  Pascal Derkinderen; François Cossais; Adrien de Guilhem de Lataillade; Laurène Leclair-Visonneau; Michel Neunlist; Sébastien Paillusson; Roberto De Giorgio
Journal:  J Neural Transm (Vienna)       Date:  2021-11-24       Impact factor: 3.850

6.  A new age for (mucosal) NeuroImmunology.

Authors:  Gerard Eberl
Journal:  Mucosal Immunol       Date:  2022-10-18       Impact factor: 8.701

Review 7.  What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?

Authors:  David A Loeffler; Jan O Aasly; Peter A LeWitt; Mary P Coffey
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

8.  Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson's Disease.

Authors:  Agata Mulak; Magdalena Koszewicz; Magdalena Panek-Jeziorna; Ewa Koziorowska-Gawron; Sławomir Budrewicz
Journal:  Front Neurosci       Date:  2019-09-27       Impact factor: 4.677

9.  Irritable bowel syndrome and subsequent risk of Parkinson's disease: a nationwide population-based matched-cohort study.

Authors:  Mun Kyung Sunwoo; Yong Wook Kim; Seo Yeon Yoon; Jaeyong Shin; Seok-Jae Heo; Jee Suk Chang
Journal:  J Neurol       Date:  2021-07-13       Impact factor: 4.849

Review 10.  TREM Receptors Connecting Bowel Inflammation to Neurodegenerative Disorders.

Authors:  Gianfranco Natale; Francesca Biagioni; Carla Letizia Busceti; Stefano Gambardella; Fiona Limanaqi; Francesco Fornai
Journal:  Cells       Date:  2019-09-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.